Registration for DO Day 2025 is open! | LEARN MORE

News

Category: Public Policy

Public Policy

Navigating the Medicare Physician Fee Schedule final rule

On Nov. 2, Centers for Medicare & Medicaid Services (CMS) issued the CY2024 Medicare Physician Fee Schedule final rule, which includes updates to physician payment policies, the Quality Payment Program (QPP) and the Medicare Shared Savings Program (MSSP). The AOA has prepared a detailed summary to help physicians prepare for changes that will take effect in … Read More

AOA Staff

11.20.23

Public Policy

Get Answers to Your Student Loan Questions with AOA Webinar

COVID policies, administration initiatives, high-interest rates and glitches with loan servicer systems. The student loan landscape has experienced significant changes and frustrations. The AOA is excited to host a webinar that will cover what to know about new student loan programs and help you get your repayment strategy on the right track. Get answers to … Read More

AOA Staff

11.08.23

Public Policy

AOA Responds to the Ways and Means Committee’s Request for Information on Issues Impacting Rural Health

On Oct. 4, the AOA responded to the Ways and Means Committee’s Request for Information on issues impacting the rural health care landscape. The letter discusses key topics that are important to the AOA and osteopathic profession, including geographic payment differences, sustainable provider financing, aligning sites of service, implementing innovative model and improving the health care workforce. … Read More

AOA Staff

11.06.23

Public Policy

Submit a Nomination for an AOA Advocacy Award

The American Osteopathic Association is currently accepting nominations for several awards designed to recognize excellence in public policy and professional advocacy on behalf of the osteopathic profession. Awards will be presented during the AOA’s DO Day 2024. The AOA’s success in advocacy couldn’t have been accomplished without the dedicated support from our members and our affiliates. Below are the … Read More

AOA Staff

11.04.23

Public Policy

AOA summary of the 2024 Medicare Physician Fee Schedule & Quality Payment Program Final Rule

Summary attributable to the AOA Public Policy Team:  On Nov. 2, the Centers for Medicare & Medicaid Services (CMS) issued the CY2024 Medicare Physician Fee Schedule final rule which includes updates to physician payment policies and the Quality Payment Program (QPP). The rule makes critical changes to payment that we want to highlight. The Public … Read More

AOA Public Policy Team

11.03.23

Public Policy

AOA Submits Statement to Energy and Commerce Committee on Patient Access and Red Tape Burdens

On Oct. 19, the Subcommittee on Health of the Committee on Energy and Commerce held a hearing on examining Medicare proposals to improve patient access to care and minimize red tape for physicians. During the hearing, Representative Michael Burgess recognized the AOA by submitting its statement for the record which addresses many issues that impact the … Read More

AOA Staff

11.02.23

Public Policy

Surprise Billing Update – No Surprise Act

CMS announces reopening the Independent Dispute Resolution (IDR) portal for new single and bundled (but not batched) claims. The Texas Medical Association (TMA) and additional plaintiffs have brought four Administrative Procedure Act (APA) challenges to the rules and guidance implementing the No Surprises Act (NSA) (termed TMA I, II, III and IV). Following the TMA III and TMA IV decisions, the IDR portal … Read More

AOA Staff

10.30.23

Public Policy

FDA Proposes Greater Oversight of Laboratory Developed Tests

In a proposed rule issued on Sept. 29, FDA seeks to strengthen its oversight of laboratory developed tests (LDTs) to improve safety, effectiveness and accuracy of such tests. LDTs are in vitro diagnostic products that the FDA has described as intended for clinical use and designed, manufactured and used within a single clinical laboratory which … Read More

AOA Staff

10.27.23

Public Policy

DEA Further Extends Telemedicine Prescribing Flexibilities

On May 10, 2023, the Drug Enforcement Administration (DEA) announced that it would extend flexibilities created during the COVID-19 public health emergency allowing physicians to prescribe controlled substances pursuant to a telemedicine encounter without first having an in-person evaluation of a patient. This rule was issued as DEA and HHS continue to consider revisions to the … Read More

AOA Staff

10.25.23